Resources: Affiliate Scholarship
“I’d feel like someone was watchin’ me… watching for a good reason”: perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with
Once-daily oral tenofovir/emtricitabine is highly effective as pre-exposure prophylaxis (PrEP) against HIV but is dependent on adherence, which may be challenging for men who have sex with men (MSM)…
Health Care Fraud: The Leading Violation of the False Claims Act
It is a sign of the times when the lion's share of the schemes intent on defrauding the federal government are in the health care arena. Data reported by…
Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi Panel
Prescription drugs and medical devices are increasingly coming to market through expedited US Food and Drug Administration (FDA) pathways that require only limited evidence of safety and efficacy, such as…
AI Insurance: How Liability Insurance Can Drive the Responsible Adoption of Artificial Intelligence in Health Care
Despite enthusiasm about the potential to apply artificial intelligence (AI) to medicine and health care delivery, adoption remains tepid, even for the most compelling technologies. In this article, the authors…
Ethics and the 2018 Practice Guideline on Disorders of Consciousness
The 2018 practice guideline on disorders of consciousness marks an important turning point in the care of patients with severe brain injury. As clinicians and health systems implement the guideline in…
Step Therapy’s Balancing Act — Protecting Patients while Addressing High Drug Prices
The debate regarding step therapy reflects a tension between two important policy goals: safeguarding patients’ access to high-quality care and constraining spending on prescription drugs, including by limiting the…
Patient Assistance Programs and the Anti-Kickback Statute: Charting a Pathway Forward
In the US health care system, as millions of patients remain uninsured and many more experience substantial cost exposures through deductibles, coinsurance, and co-payments,1 some have turned to patient assistance…
When Desperate Patients Go to Court for Unproven Treatments — The Battle for Hospital Independence
During the Covid-19 pandemic, patients have asked courts to compel hospitals to administer unproven therapies, including ivermectin. These lawsuits have called into question the judiciary’s role in medical…
Distributed Governance of Medical AI
Artificial intelligence (AI) promises to bring substantial benefits to medicine. In addition to pushing the frontiers of what is humanly possible, like predicting kidney failure or sepsis before any human…
SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored
On November 15, 2021, the US Department of Health and Human Services (HHS) rescinded a Trump-era policy that had directed the US Food and Drug Administration (FDA) to discontinue the premarket reviews…
Mitigating Racial Bias in Machine Learning
When applied in the health sector, AI-based applications raise not only ethical but legal and safety concerns, where algorithms trained on data from majority populations can generate less accurate or…
Introduction: Health Law and Anti-Racism: Reckoning and Response
Law and racism are intertwined, with legal tools bearing the potential to serve as instruments of oppression or equity. This Special Issue explores this dual nature of health law, with…
Reflections on Paul Farmer’s legacy: a clarion call for transformative human rights praxis in global health
Paul Farmer’s far-too-early passing on February 21, 2022 is an incalculable loss to those of us who knew and loved him, to students and patients around the globe, to the…
How do we encourage innovation on “long COVID”?
Since the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. Whether such a condition is…
Travel restrictions and variants of concern: global health laws need to reflect evidence
As the coronavirus disease 2019 (COVID-19) spread in the early days of the pandemic, governments neglected World Health Organization (WHO) guidance and imposed travel restrictions. These public health measures employed varied…
Artificial Intelligence in Healthcare
Artificial intelligence (AI) is poised to significantly impact healthcare systems, including clinical diagnosis, healthcare administration and delivery, and public health infrastructures. In the context of the Quintuple Aim of healthcare …
Institutional Review Board Use of Outside Experts: What Do We Know?
Institutional review boards (IRBs) are permitted by regulation to seek assistance from outside experts when reviewing research applications that are beyond the scope of expertise represented in their membership. There…
Transparency and the Doctor–Patient Relationship — Rethinking Conflict-of-Interest Disclosures
To reduce the harm associated with improper financial relationships between manufacturers and physicians, practitioners could be required to disclose such relationships directly to patients.
On Sea Monsters and Sandcastles: Revisiting International Legal Frameworks regarding Public Health and Human Rights in Global Health Emergencies
As a new coronavirus, SARS-CoV-2, swept across the globe with unprecedented speed in 2020, countries were faced with navigating between the proverbial Scylla and Charybdis. In a quickly evolving situation, with…
Patents on Psychedelics: The Next Legal Battlefront of Drug Development
In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for…